Skip to content
Annalist
Companies Compare Method Data Quality For AI agents

AbbVie Inc.

ABBV · NYSE · Health care, pharmaceuticals · United States · US GAAP · Fiscal year ends December

Latest report: Q2 FY2026, the quarter ended 30 June 2026, released 3 August 2026. Snapshot FY2026Q2_c0beb545.

Overview

Revenue, quarter
+10.2% year on year
Operating income, quarter
+31.4% year on year
Net income, quarter
+285% year on year
Diluted EPS, quarter
+290% year on year
Operating margin, last 4 quarters
+7.4pp year on year
Return on invested capital, last 4 quarters
−0.4pp year on year

Select a figure to see the document it came from.

Key Findings

Findings for the latest quarter, with their history over earlier quarters.

  1. Revenue for the quarter ended 30 June 2026 was US$17.0 billion, 10.2% higher than in the same quarter a year earlier.

    Weakenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Revenue against a year earlier · Sources 10-Q 2026-06
    History of this finding, 9 records
    1. Q2 FY2026 WeakenedRevenue for the quarter ended 30 June 2026 was US$17.0 billion, 10.2% higher than in the same quarter a year earlier.Recorded from FY2026Q2_c788d925 · data update
    2. Q1 FY2026 StrengthenedRevenue for the quarter ended 31 March 2026 was US$15.0 billion, 12.4% higher than in the same quarter a year earlier.Reconstructed · data update
    3. Q4 FY2025 ConfirmedRevenue for the quarter ended 31 December 2025 was US$16.6 billion, 10.0% higher than in the same quarter a year earlier.Reconstructed · data update
    4. Q3 FY2025 StrengthenedRevenue for the quarter ended 30 September 2025 was US$15.8 billion, 9.1% higher than in the same quarter a year earlier.Reconstructed · data update
    5. Q2 FY2025 WeakenedRevenue for the quarter ended 30 June 2025 was US$15.4 billion, 6.6% higher than in the same quarter a year earlier.Reconstructed · data update
    6. Q1 FY2025 StrengthenedRevenue for the quarter ended 31 March 2025 was US$13.3 billion, 8.4% higher than in the same quarter a year earlier.Reconstructed · data update
    7. Q4 FY2024 StrengthenedRevenue for the quarter ended 31 December 2024 was US$15.1 billion, 5.6% higher than in the same quarter a year earlier.Reconstructed · data update
    8. Q3 FY2024 ConfirmedRevenue for the quarter ended 30 September 2024 was US$14.5 billion, 3.8% higher than in the same quarter a year earlier.Reconstructed · data update
    9. Q2 FY2024 NewRevenue for the quarter ended 30 June 2024 was US$14.5 billion, 4.3% higher than in the same quarter a year earlier.Reconstructed · initial
  2. Net income attributable to the company was US$3.6 billion, 285.2% higher than in the same quarter a year earlier.

    Newin Q2 FY2026 · first stated
    Rule: Net income against a year earlier · Sources 10-Q 2026-06
    History of this finding, 14 records
    1. Q2 FY2026 NewNet income attributable to the company was US$3.6 billion, 285.2% higher than in the same quarter a year earlier.Recorded from FY2026Q2_c788d925 · data update
    2. Q2 FY2026 RetiredThe finding changed to higher than a year earlier.Recorded from FY2026Q2_c788d925 · data update
    3. Q1 FY2026 NewNet income attributable to the company was US$695 million, 46.0% lower than in the same quarter a year earlier.Reconstructed · data update
    4. Q1 FY2026 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    5. Q4 FY2025 NewNet income attributable to the company was US$1.8 billion, against a net loss of US$22 million in the same quarter a year earlier.Reconstructed · data update
    6. Q4 FY2025 RetiredThe finding changed to a profit after a loss a year earlier.Reconstructed · data update
    7. Q3 FY2025 StrengthenedNet income attributable to the company was US$186 million, 88.1% lower than in the same quarter a year earlier.Reconstructed · data update
    8. Q2 FY2025 StrengthenedNet income attributable to the company was US$938 million, 31.5% lower than in the same quarter a year earlier.Reconstructed · data update
    9. Q1 FY2025 NewNet income attributable to the company was US$1.3 billion, 6.1% lower than in the same quarter a year earlier.Reconstructed · data update
    10. Q1 FY2025 RetiredThe finding changed to lower than a year earlier.Reconstructed · data update
    11. Q4 FY2024 NewThe company reported a net loss of US$22 million, against net income of US$822 million in the same quarter a year earlier.Reconstructed · data update
    12. Q4 FY2024 RetiredThe finding changed to a loss.Reconstructed · data update
    13. Q3 FY2024 WeakenedNet income attributable to the company was US$1.6 billion, 12.2% lower than in the same quarter a year earlier.Reconstructed · data update
    14. Q2 FY2024 NewNet income attributable to the company was US$1.4 billion, 32.3% lower than in the same quarter a year earlier.Reconstructed · initial
  3. The operating margin over the last 4 quarters was 26.2%, 7.4 percentage points higher than a year earlier.

    Strengthenedin Q2 FY2026 · stated since Q4 FY2025
    Rule: Operating margin against a year earlier · Sources 10-Q 2025-09, 10-K 2025-12, 10-Q 2026-03 and 2 more
    History of this finding, 10 records
    1. Q2 FY2026 StrengthenedThe operating margin over the last 4 quarters was 26.2%, 7.4 percentage points higher than a year earlier.Recorded from FY2026Q2_c788d925 · data update
    2. Q1 FY2026 WeakenedThe operating margin over the last 4 quarters was 24.4%, 6.8 percentage points higher than a year earlier.Reconstructed · data update
    3. Q4 FY2025 NewThe operating margin over the last 4 quarters was 24.6%, 8.4 percentage points higher than a year earlier.Reconstructed · data update
    4. Q4 FY2025 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    5. Q3 FY2025 StrengthenedThe operating margin over the last 4 quarters was 15.2%, 9.7 percentage points lower than a year earlier.Reconstructed · data update
    6. Q2 FY2025 WeakenedThe operating margin over the last 4 quarters was 18.8%, 3.5 percentage points lower than a year earlier.Reconstructed · data update
    7. Q1 FY2025 WeakenedThe operating margin over the last 4 quarters was 17.6%, 5.9 percentage points lower than a year earlier.Reconstructed · data update
    8. Q4 FY2024 StrengthenedThe operating margin over the last 4 quarters was 16.2%, 7.3 percentage points lower than a year earlier.Reconstructed · data update
    9. Q3 FY2024 WeakenedThe operating margin over the last 4 quarters was 24.9%, 2.4 percentage points lower than a year earlier.Reconstructed · data update
    10. Q2 FY2024 NewThe operating margin over the last 4 quarters was 22.3%, 8.7 percentage points lower than a year earlier.Reconstructed · initial
  4. Return on invested capital over the last 4 quarters was 18.1%, against 18.5% a year earlier.

    Weakenedin Q2 FY2026 · stated since Q1 FY2026
    Rule: Return on invested capital against a year earlier · Sources 10-Q 2025-06, 10-Q 2026-06, 10-Q 2025-09 and 3 more
    History of this finding, 2 records
    1. Q2 FY2026 WeakenedReturn on invested capital over the last 4 quarters was 18.1%, against 18.5% a year earlier.Recorded from FY2026Q2_c788d925 · data update
    2. Q1 FY2026 NewReturn on invested capital over the last 4 quarters was 13.6%, against 15.2% a year earlier.Reconstructed · initial
  5. Free cash flow over the last 4 quarters was US$18.2 billion, and operating cash flow was 3.1 times net income attributable to the company.

    Interpretation. Operating cash flow paid for all capital expenditure, and the rest is free for dividends, share buybacks or debt repayment.

    Weakenedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Free cash flow · Sources 10-Q 2025-06, 10-Q 2025-09, 10-K 2025-12 and 2 more
    History of this finding, 9 records
    1. Q2 FY2026 WeakenedFree cash flow over the last 4 quarters was US$18.2 billion, and operating cash flow was 3.1 times net income attributable to the company.Recorded from FY2026Q2_c788d925 · data update
    2. Q1 FY2026 StrengthenedFree cash flow over the last 4 quarters was US$20.0 billion, and operating cash flow was 5.8 times net income attributable to the company.Reconstructed · data update
    3. Q4 FY2025 WeakenedFree cash flow over the last 4 quarters was US$17.8 billion, and operating cash flow was 4.5 times net income attributable to the company.Reconstructed · data update
    4. Q3 FY2025 StrengthenedFree cash flow over the last 4 quarters was US$19.7 billion, and operating cash flow was 8.7 times net income attributable to the company.Reconstructed · data update
    5. Q2 FY2025 StrengthenedFree cash flow over the last 4 quarters was US$18.2 billion, and operating cash flow was 5.1 times net income attributable to the company.Reconstructed · data update
    6. Q1 FY2025 WeakenedFree cash flow over the last 4 quarters was US$15.4 billion, and operating cash flow was 3.9 times net income attributable to the company.Reconstructed · data update
    7. Q4 FY2024 StrengthenedFree cash flow over the last 4 quarters was US$17.8 billion, and operating cash flow was 4.4 times net income attributable to the company.Reconstructed · data update
    8. Q3 FY2024 WeakenedFree cash flow over the last 4 quarters was US$15.6 billion, and operating cash flow was 3.2 times net income attributable to the company.Reconstructed · data update
    9. Q2 FY2024 NewFree cash flow over the last 4 quarters was US$17.8 billion, and operating cash flow was 3.5 times net income attributable to the company.Reconstructed · initial
  6. Net debt was US$64.3 billion at 30 June 2026, 2.6 times EBITDA over the last 4 quarters.

    Confirmedin Q2 FY2026 · stated since Q2 FY2024
    Rule: Net debt or net cash · Sources 10-Q 2026-06, 10-Q 2025-06, 10-Q 2025-09 and 2 more
    History of this finding, 10 records
    1. Q2 FY2026 ConfirmedNet debt was US$64.3 billion at 30 June 2026, 2.6 times EBITDA over the last 4 quarters.Recorded from FY2026Q2_51464d45 · correction
    2. Q2 FY2026 ConfirmedNet debt was US$64.3 billion at 30 June 2026, 3.6 times EBITDA over the last 4 quarters.Recorded from FY2026Q2_c788d925 · data update
    3. Q1 FY2026 ConfirmedNet debt was US$63.5 billion at 31 March 2026, 3.9 times EBITDA over the last 4 quarters.Reconstructed · data update
    4. Q4 FY2025 ConfirmedNet debt was US$62.2 billion at 31 December 2025, 3.9 times EBITDA over the last 4 quarters.Reconstructed · data update
    5. Q3 FY2025 ConfirmedNet debt was US$63.1 billion at 30 September 2025, 6.4 times EBITDA over the last 4 quarters.Reconstructed · data update
    6. Q2 FY2025 ConfirmedNet debt was US$64.0 billion at 30 June 2025, 5.5 times EBITDA over the last 4 quarters.Reconstructed · data update
    7. Q1 FY2025 StrengthenedNet debt was US$64.7 billion at 31 March 2025, 6.0 times EBITDA over the last 4 quarters.Reconstructed · data update
    8. Q4 FY2024 ConfirmedNet debt was US$61.6 billion at 31 December 2024, 6.2 times EBITDA over the last 4 quarters.Reconstructed · data update
    9. Q3 FY2024 StrengthenedNet debt was US$63.8 billion at 30 September 2024, 4.4 times EBITDA over the last 4 quarters.Reconstructed · data update
    10. Q2 FY2024 NewNet debt was US$57.5 billion at 30 June 2024, 4.4 times EBITDA over the last 4 quarters.Reconstructed · initial

Records before Q2 FY2026 are reconstructed from the latest snapshot. Ledger: findings.json. Correction of 20 October 2026: Annalist left the amortisation of intangible assets that AbbVie reports on a line of its own out of depreciation and amortisation: US$0.76 billion for 2025 against US$8.14 billion with it. EBITDA and the credit metrics built on it were understated. 6 dividends per share of the first 3 quarters of 2022 and 2023, which the set of filings of their quarter does not report, are no longer published. Records 104 to 106 state the corrected findings: lease-adjusted debt of 2.8 times adjusted EBITDA over the 4 quarters to 30 June 2026, in the intermediate band, where the significant band was stated. Records 6, 7, 19, 29, 31, 44, 52, 60, 70, 72, 85, 95, 98 and 102 cite figures that the correction changed.

Credit, liquidity, earnings quality and score findings: Analysis.

Findings No Longer Stated

Rules whose findings applied in earlier quarters but not in the latest one.

  • Return on equity against a year earlier · retired in Q1 FY2026
    1. Q1 FY2026 RetiredThe rule did not apply to the figures as at Q1 FY2026.Reconstructed · data update
    2. Q4 FY2025 StrengthenedReturn on equity over the last 4 quarters was 15,367.3%, against 62.5% a year earlier.Reconstructed · data update
    3. Q3 FY2025 StrengthenedReturn on equity over the last 4 quarters was 140.9%, against 56.5% a year earlier.Reconstructed · data update
    4. Q2 FY2025 StrengthenedReturn on equity over the last 4 quarters was 114.1%, against 54.4% a year earlier.Reconstructed · data update
    5. Q1 FY2025 StrengthenedReturn on equity over the last 4 quarters was 89.0%, against 56.3% a year earlier.Reconstructed · data update
    6. Q4 FY2024 StrengthenedReturn on equity over the last 4 quarters was 62.5%, against 35.2% a year earlier.Reconstructed · data update
    7. Q3 FY2024 NewReturn on equity over the last 4 quarters was 56.5%, against 46.4% a year earlier.Reconstructed · data update
    8. Q3 FY2024 RetiredThe finding changed to higher than a year earlier.Reconstructed · data update
    9. Q2 FY2024 NewReturn on equity over the last 4 quarters was 54.4%, against 63.1% a year earlier.Reconstructed · initial

Data

Source documents27 documents, latest Form 10-Q, period ended 30 June 2026List
DownloadsExcel workbook · JSON
SnapshotFY2026Q2_c0beb545

Corporate Events

  1. Acquisitions paid in cash31 December 2024

    Paid US$17.5 billion in cash for business acquisitions in fiscal 2024, 13.0% of total assets at the start of the year.

    Source 10-K 2025-12
  2. Acquisition8 May 2020

    Completed the acquisition of Allergan plc.

    Source 8-K 2020-05

Earnings, Returns and Balance Sheet

Revenue

By quarter, US dollars

Operating Income

By quarter, US dollars

Net Income Attributable to the Company

By quarter, US dollars

Margins

Last 4 quarters at each quarter end, per cent

Returns

Last 4 quarters, per cent

Free Cash Flow

Operating cash flow less capital expenditure, by quarter, US dollars

Net Debt

Total debt less cash and short-term investments, at quarter end, US dollars

Diluted Earnings per Share

By quarter, as reported

Financial Statements

Figures as filed. Select a figure for its source document and method; a small d marks a quarter derived from cumulative reports.

The statements are loading. They are also available as JSON and CSV.

Ratios

Select a ratio for its formula and the figures it uses, each with its document; (i) gives its definition.

The ratios are loading.

Source Documents

Documents of this snapshot, latest first.

DocumentDateId
Form 10-Q, period ended 30 June 20263 Aug 202610-Q:0001551152-26-000026
Form 10-Q, period ended 31 March 20268 May 202610-Q:0001551152-26-000017
Form 10-K, period ended 31 December 202520 Feb 202610-K:0001551152-26-000008
Form 10-Q, period ended 30 September 20254 Nov 202510-Q:0001551152-25-000049
Form 10-Q, period ended 30 June 20254 Aug 202510-Q:0001551152-25-000040
Form 10-Q, period ended 31 March 20259 May 202510-Q:0001551152-25-000029
Form 10-K, period ended 31 December 202414 Feb 202510-K:0001551152-25-000020
Form 10-Q, period ended 30 September 20244 Nov 202410-Q:0001551152-24-000040
Form 10-Q, period ended 30 June 20247 Aug 202410-Q:0001551152-24-000031
Form 10-Q, period ended 31 March 20243 May 202410-Q:0001551152-24-000020
Form 10-K, period ended 31 December 202320 Feb 202410-K:0001551152-24-000011
Form 10-Q, period ended 30 September 20236 Nov 202310-Q:0001551152-23-000045
Form 10-Q, period ended 30 June 20237 Aug 202310-Q:0001551152-23-000033
Form 10-Q, period ended 31 March 20235 May 202310-Q:0001551152-23-000023
Form 10-K, period ended 31 December 202217 Feb 202310-K:0001551152-23-000011
Form 10-Q, period ended 30 September 20224 Nov 202210-Q:0001551152-22-000045
Form 10-Q, period ended 30 June 20224 Aug 202210-Q:0001551152-22-000030
Form 10-Q, period ended 31 March 20226 May 202210-Q:0001551152-22-000017
Form 10-K, period ended 31 December 202118 Feb 202210-K:0001551152-22-000007
Form 10-Q, period ended 30 September 20212 Nov 202110-Q:0001551152-21-000031
Form 10-Q, period ended 30 June 20212 Aug 202110-Q:0001551152-21-000025
Form 10-Q, period ended 31 March 20217 May 202110-Q:0001551152-21-000016
Form 10-K, period ended 31 December 202019 Feb 202110-K:0001551152-21-000008
Form 10-Q, period ended 30 September 20204 Nov 202010-Q:0001551152-20-000032
Form 10-Q, period ended 30 June 20204 Aug 202010-Q:0001551152-20-000023
Form 8-K, period ended 8 May 20208 May 20208-K:0001104659-20-058837
Form 10-Q, period ended 31 March 20208 May 202010-Q:0001551152-20-000015

Checks

294285 of 294 checks passed, 9 warnings
Fiscal calendar68 passedFiscal years last 350 to 380 days, quarters 80 to 125 days, and each period starts on the day after the one before. Checked at error level.
Quarters and fiscal year151 of 153 passedThe 4 quarters of every item add up to its fiscal year, or a later filing restated the year. Checked at error level; a difference that a later report explains is a warning, which does not stop publication.
Research and development expense, FY2020: $6,557m against $6,379m
Increase in accounts payable, FY2021: $1,628m against $1,719m
Reported quarters0 of 7 passedA quarter that a filing reports on its own agrees with the figures of the same filing. Checked at warning level.
Net income available to common shareholders, Q3 FY2021: $3,158m against $3,160m
Amortisation of intangible assets, Q3 FY2020: $2,100m against $2,117m
Amortisation of intangible assets, Q3 FY2021: $1,900m against $1,904m
Amortisation of intangible assets, Q3 FY2022: $2,000m against $2,024m
Amortisation of intangible assets, Q3 FY2023: $2,000m against $2,039m
Amortisation of intangible assets, Q3 FY2024: $1,900m against $1,888m
Filer identity1 passedThe documents are those of the company of this page. Checked at error level.
Balance sheet identity26 passedTotal assets equal total liabilities and equity at each balance sheet date. Checked at error level.
Lease liabilities6 passedLease payments due, less imputed interest, equal the lease liabilities. Checked at warning level.
Debt maturities6 passedThe debt maturity schedule adds up to the long-term debt. Checked at warning level.
Quarters and 9 months15 passedThe 3 reported quarters of a fiscal year add up to the reported 9-month figure. Checked at error level.
Gross profit6 passedRevenue less cost of revenue equals reported gross profit. Checked at warning level.
Earnings per share6 passedNet income divided by average shares agrees with reported basic earnings per share. Checked at warning level.

Data Quality

How many values of this snapshot the checks prove, and how many Annalist derives, withholds and tracks as restated. Every company.

Values published1,569
Proven by a check51.8%, 813 values
Confirmed by a second document0.0%, 0 values
Derived from reported figures20.8%, 327 values
Values withheld0
Restated figures tracked12
Changes compared on one basis0
Company lines mapped0 of 0 reviewed

Citation

Annalist, AbbVie Inc., snapshot abbvie/FY2026Q2_c0beb545 (as of FY2026 Q2); <item label>, <period>; source <document id> (<document url>)

Snapshot FY2026Q2_c0beb545 · dataset SHA-256 c0beb545007b6e6246534288c911f21dcf60f8eef2c74e3b2ee1914c705d8ce3 · findings rules 0.4

Data: info.json · dataset.json · validation.json · documents.json